News & Articles
Selected Filters:
Novel "hydrogel" carriers for anti-cancer drugs offer new hope for cancer treatment
Anti-cancer drug delivery to target tumor sites now becomes more effective with novel multi-stimuli-responsive drug delivery systems
Cancer immunotherapies: How single-cell sequencing can aid informed decision-making
An insider’s view on leveraging the latest single-cell technologies, including cell sorting and single-cell sequencing, to understand what drives response or resistance in checkpoint therapies
Keeping up with COVID-19: Designing novel monitoring assays to tackle the rise of variants
Dr. Tania Nolan outlines how her team is designing assays to identify new variants and why these are critical to managing the global response
LGC’s ValuPanel Reagents help public laboratories detect SARS-CoV-2 and influenza
Each line of ValuPanel Reagents consists of separately delivered probes and primers, which allow assay flexibility and sizes that can help facilitate scale-up
Artificial Intelligence could create better outcomes for bowel cancer patients
AI could hold the key to more targeted treatment, according to new research
Virtual Cancer and Immunology Research Summit 2021: Full meeting agenda
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
Organoid-based 3D model of human glioblastoma: Recreating brain tumors in a dish
Discover how a brain organoid core facility is applying its glioblastoma model towards developing patient mini-brains
Scientific study identifies ion channel components as critical regulators of neuronal connections
In a ten-year project, a team from the Karl Landsteiner University of Health Sciences has identified a previously unknown role of calcium channels in the formation of synaptic connections
Getting ready for In Vitro Diagnostic Regulation (IVDR)
Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR
IONTAS identifies novel SARS-CoV-2 neutralizing antibodies
Potent antibodies shown to retain binding to major COVID-19-causing “South African” variant
Thermo Fisher Scientific, Mayo Clinic partner on new diagnostic tools
The partnership will accelerate clinical validation and commercialization of certain NGS, mass spectrometry and immunology diagnostic tools
Thermo Fisher Scientific completes FDA listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System
Innovative qPCR platform simplifies molecular diagnostic workflows for infectious disease, oncology and COVID-19 testing
Twist Bioscience and Biotia receive FDA EUA for hybridization-based NGS SARS-CoV-2 assay
The assay has the ability to sequence and surveil evolution of virus mutations over time and geography
New data published from Women & Infants Hospital demonstrate utility of predictive immune modeling in ovarian cancer
This study offers new insights into high grade serous ovarian cancer that have the potential to make an impact in how patients are treated in the future
Aptamer Group and Mologic partner to develop aptamer-based SARS-CoV-2 rapid antigen test
This partnership aims to offer an accelerated route to market rapid test technologies
Beckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from FDA
Lenco Diagnostic Laboratories among first to offer Beckman Coulter’s semi-quantitative antibody test
USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Oxford-AstraZeneca coronavirus vaccine 79% effective against symptomatic COVID-19 overall
'Communication makes knowledge more accessible’
This week’s Reviewer in the Spotlight, Dr. Ritesh Bhole, discusses communication in science and the value of genuine product reviews, both positive and negative
AstraZeneca provides an update on the safety of the COVID-19 vaccine
The monthly safety report will be made public on the European Medicines Agency website
UK researchers identify inflammatory protein linked to severe COVID-19
The findings come from the largest study to date to look at inflammatory markers in COVID-19